Publications by authors named "Eric A Sheldon"

Claim this Profile
S
Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study.
D Gray Heppner, Tracy L Kemp, Brian K Martin, William J Ramsey, Richard Nichols, Eric A Sheldon

Lancet Infect Dis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.
C Buddy Creech, Robert W Frenck, Eric A Sheldon, David J Seiden, Martin K Kankam

Vaccine· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study.
Robert W Frenck, C Buddy Creech, Eric A Sheldon, David J Seiden, Martin K Kankam

Vaccine· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial.
Chan R Beals, Radha A Railkar, Andrea K Schaeffer, Yotam Levin, Efrat Kochba, Eric A Sheldon

Lancet Infect Dis· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults.
Robert J Hopkins, Gurdyal Kalsi, Victor M Montalvo-Lugo, Mona Sharma, Yukun Wu, Eric A Sheldon

Vaccine· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*.
Eric A Sheldon, Robert Jeanfreau, Joseph A Sliman, Supoat Charenkavanich, Matthew D Rousculp

Influenza Other Respir Viruses· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response.
David N Taylor, John J Treanor, Eric A Sheldon, Casey Johnson, Scott Umlauf

Vaccine· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1, randomized, open-label, active-controlled trial to assess the safety of a meningococcal serogroup B bivalent rLP2086 vaccine in healthy adults.
Eric A Sheldon, Howard Schwartz, Qin Jiang, Peter C Giardina, John L Perez

Hum Vaccin Immunother· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
Alan Kivitz, Michael Fairfax, Eric A Sheldon, Qinfang Xiang, Beverly A Jones

Clin Ther· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of measures of pain, function, and overall response: results pooled from two identical studies of etoricoxib in chronic low back pain.
Eric A Sheldon, Steven R Bird, Steven S Smugar, Andrew M Tershakovec

Spine (Phila Pa 1976)· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial.
Craig W Wiesenhutter, Judith A Boice, Amy Ko, Eric A Sheldon, Frederick T Murphy

Mayo Clin Proc· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.
Charles A Birbara, Anthony D Puopolo, David R Munoz, Eric A Sheldon, Antoinette Mangione

J Pain· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis